TO THE QUESTION ABOUT FACTORS OF EMERGENCE, SPREAD AND MODERN METHODS OF DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS (scientific review)
Abstract
Keywords
About the Authors
Dmitry Alekseevich KonovalovRussian Federation
Igor Nikolaevich Bobrovsky
Russian Federation
Valeria Nikolaevna Orobinskaya
Russian Federation
Elena Mikhailovna Kasparova
Russian Federation
References
1. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69-90. doi: 10.3322/caac.20107.
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M. J. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58:71-96. doi:10.3322/CA.2007.0010.
3. Partridge E. E., Barnes M. N. Epithelial ovarian cancer: prevention, diagnosis, and treatment. CA Cancer J Clin. 1999; 49:297-320. doi: 10.3322/canjclin.49.5.297.
4. Ries L. A., Melbert D., Krapcho M. et al, editor. SEER cancer statistics review, 1975-2004. Bethesda, Md.: National Cancer Institute; 2007.
5. Seidman J. D., Horkayne-Szakaly I., Haiba M., Boice C. R., Kurman R. J., Ronnett B. M. The histologic type and stage distribution of ovarian carcinomas ofsurface epithelial origin. Int J Gynecol Pathol. 2004; 23:41-44. doi: 10.1097/01.pgp.0000101080.35393.16.
6. Yiying Wang, Maggie Mang, Yue Wang, Lijie Wang, Robert Klein, Beihua Kong, and Wenxin Zheng Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma // Am J Cancer Res. 2015; 5(3): 869-879
7. Colgan T. J., Murphy J., Cole D. E., Narod S., Rosen B. Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status. Am J Surg Pathol. 2001; 25:1283-1289. doi: 10.1097/00000478-200110000-00009.
8. Powell C. B., Kenley E., Chen L. M., Crawford B., McLennan J., Zaloudek C., Komaromy M., Beattie M., Ziegler J. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. J Clin Oncol. 2005; 23:127-132.
9. Medeiros F., Muto M. G., LeeY., Elvin J. A., Callahan M. J., Feltmate C., GarberJ. E., Cramer D. W., Crum C. P. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006; 30:230-236. doi: 10.1097/01.pas.0000180854.28831.77.
10. Lee Y., Miron A., Drapkin R., Nucci M. R., Medeiros F., Saleemuddin A., Garber J., Birch C., Mou H., Gordon R. W. et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007; 211:26-35. doi: 10.1002/path.2091.
11. Mehrad M., Ning G., Chen E. Y., Mehra K. K., Crum C. P. A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube. Adv Anat Pathol. 2010; 17:293-302.
Review
For citations:
Konovalov D.A., Bobrovsky I.N., Orobinskaya V.N., Kasparova E.M. TO THE QUESTION ABOUT FACTORS OF EMERGENCE, SPREAD AND MODERN METHODS OF DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS (scientific review). Modern Science and Innovations. 2015;(4):112-118. (In Russ.)